1.
Yao W, Xinchen Fang, Peng Jiang, Juan Tong, Liangquan Geng, Xiaoyu Zhu, et al. Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation: Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF. Mediterr J Hematol Infect Dis [Internet]. 2022 Feb. 27 [cited 2024 Jul. 23];14(1):e2022025. Available from: https://www.mjhid.org/mjhid/article/view/4856